| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |